Objective To explore the expression of CD59 antigen from patients with haematological malignancies and its clinical significance.
目的探讨CD5 9抗原在血液系统恶性肿瘤患者红细胞及成熟粒细胞上的表达及意义。
Patients with haematological malignancies receiving intensive chemotherapy and requiring hospitalization were randomized in a double-blind, placebo-controlled single-centre trial.
入院接受密集化疗的血液学恶性肿瘤的病人被随机分为两组，在单中心实验中用双盲法处理安慰剂组和控制组。
应用推荐